Cal-Maine Foods Inc: Form 10-Q for the period ended Mar 1, 2025
Filed with the SEC on Apr 8, 2025 and accepted by EDGAR at Apr 8, 2025, 20:31 ET.
Management's discussion and analysis
As filed, 2,463 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results
of Operations included in Part II Item 7 of the Company’s Annual Report on Form 10-K for its fiscal year ended June 1, 2024
(the “2024 Annual Report”), and the accompanying financial statements and notes included in Part II Item 8 of the 2024 Annual
Report and in
Part I Item 1
of this Quarterly Report on Form 10-Q (“Quarterly Report”).
This report contains numerous forward-looking statements within the meaning of Section 27A of the Securities Act of 1933
(the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”) relating to our shell egg
and egg products business, including estimated future production data, expected construction schedules, projected construction
costs, potential future supply of and demand for our products, potential future corn and soybean price trends, potential future
impact on our business of the resurgence in United States (“U.S.”) commercial table egg layer flocks of highly pathogenic avian
influenza (“HPAI”), potential future impact on our business of inflation and changing interest rates, potential future impact on
our business of new legislation, rules or policies, potential outcomes of legal proceedings, including loss contingency accruals
and factors that may result in changes in the amounts recorded, and other projected operating data, including anticipated results
of operations and financial condition. Such forward-looking statements are identified by the use of words such as “believes,”
“intends,” “expects,” “hopes,” “may,” “should,” “plans,” “projected,” “contemplates,” “anticipates,” or similar words. Actual
outcomes or results could differ materially from those projected in the forward-looking statements. The forward-looking
statements are based on management’s current intent, belief, expectations, estimates, and projections regarding the Company
and its industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and
other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ
materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in Part II
Market risk
As filed, 253 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in our exposure to market risk during the thirty-nine weeks ended March 1, 2025 from the
information provided in Part II Item 7A, Quantitative and Qualitative Disclosures About Market Risk in our 2024 Annual
Report.
Controls and procedures
As filed, 1,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
AND
PROCEDURES
Disclosure Controls and Procedures
Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed
by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time
periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include,
without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that
we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive
and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding
required disclosure. Based on an evaluation of our disclosure controls and procedures conducted by our Chief Executive Officer
and Chief Financial Officer, together with other financial officers, such officers concluded that our disclosure controls and
procedures were effective as of March 1, 2025 at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the quarter ended March 1, 2025 that
has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 50,197 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
10-K for the year ended June 1, 2024, as well as those included in other reports we file from time to time with the SEC
(including our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K), (ii) the effect of the potential conversion of
all of the Company’s Class A Common Stock into Common Stock and resulting loss by the Company of controlled company
status under the rules of The Nasdaq Stock Market on the trading price of the Company’s Common Stock, the ability of the
Company to retain and hire key personnel and maintain relationships with its customers and suppliers, and on the Company’s
operating results and business generally, (iii) the impact on the trading price of the Company’s Common Stock as a result of
the sale or marketing, or potential sale or marketing, of a significant number of shares of the Company’s Common Stock held
by the family of our late founder, Fred R. Adams Jr., as part of their potential portfolio diversification efforts, (iv) the risks and
hazards inherent in the shell egg business (including disease, pests, weather conditions, and potential for product recall),
including but not limited to the current outbreak of HPAI affecting poultry in the U.S., Canada and other countries that was first
detected in commercial flocks in the U.S. in February 2022 and that first impacted our flocks in December 2023, (v) changes in
the demand for and market prices of shell eggs and feed costs, (vi) the impacts and potential future impacts of government,
customer and consumer reactions to recent high market prices for eggs, including but not limited to efforts to increase imports
of eggs and egg products, pressure to change long-standing pricing frameworks, lower consumer demand for eggs, and the
pending DOJ antitrust investigation, (vii) our ability to predict and meet demand for cage-free and other specialty eggs, (viii)
risks, changes, or obligations that could result from our recent or future acquisition of new flocks or businesses and risks or
changes that may cause conditions to completing a pending acquisition, such as the pending acquisition of Echo Lake Foods,
not to be met, (ix) risks relating to changes in inflation and interest rates, (x) our ability to retain existing customers, acquire
new customers and grow our product mix, (xi) adverse results in pending litigation and other legal matters, and (xii) global
instability, including as a result of the war in Ukraine, the conflicts in Israel and surrounding areas and attacks on shipping in
the Red Sea. Readers are cautioned not to place undue reliance on forward-looking statements because, while we believe the
assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-
looking statements will prove to be accurate. Further, forward-looking statements included herein are made only as of the
respective dates thereof, or if no date is stated, as of the date hereof. Except as otherwise required by law, we disclaim any
intent or obligation to update publicly these forward-looking statements, whether because of new information, future events, or
otherwise.
GENERAL
Cal-Maine Foods, Inc. (the “Company,” “we,” “us,” “our”) is primarily engaged in the production, grading, packaging,
marketing and distribution of fresh shell eggs. Our operations are fully integrated and we have one operating and reportable
segment. We are the largest producer and distributor of fresh shell eggs in the U.S. Our total flock of approximately 48.9
million layers and 12.3 million pullets and breeders is the largest in the U.S. We sell our shell eggs and egg products to a
diverse group of customers, including national and regional grocery store chains, club stores, companies servicing independent supermarkets in the U.S., foodservice distributors and egg product customers throughout the majority of the U.S. and aim to maintain efficient, state-of-the-art operations located close to our customers.
Our operating results are materially impacted by market prices for eggs and feed grains (corn and soybean meal), which are
highly volatile, independent of each other, and out of our control. Generally, higher market prices for eggs have a positive
impact on our financial results while higher market prices for feed grains have a negative impact on our financial results.
Although we use a variety of pricing frameworks with our customers for conventional and specialty eggs, we sell most of our
conventional shell eggs based on formulas that consider, in varying ways, independently quoted regional wholesale market
prices for shell eggs or formulas related to our costs of production which include the cost of corn and soybean meal. We sell the
majority of our specialty eggs at prices and terms negotiated directly with our customers. We do not sell eggs directly to
consumers or set the prices at which eggs are sold to consumers.
Retail sales of shell eggs historically have been highest during the fall and winter months and lowest during the summer
months. Prices for shell eggs fluctuate in response to seasonal demand factors and a natural increase in egg production during
the spring and early summer. Historically, shell egg prices tend to increase with the start of the school year and tend to be
highest prior to holiday periods, particularly Thanksgiving, Christmas and Easter. Consequently, and all other things being
equal, we would expect to experience lower selling prices, sales volumes and net income (and may incur net losses) in our first
and fourth fiscal quarters ending in August/September and May/June, respectively. Because of the seasonal and quarterly
fluctuations, comparisons of our sales and operating results between different quarters within a single fiscal year are not
necessarily meaningful comparisons.
We routinely fill our storage bins during harvest season when prices for feed ingredients are generally lower. To ensure
continued availability of feed ingredients, we may enter into contracts for future purchases of corn and soybean meal, and as
part of these contracts, we may lock-in the basis portion of our grain purchases several months in advance. Basis is the
difference between the local cash price for grain and the applicable futures price. A basis contract is a common transaction in
the grain market that allows us to lock-in a basis level for a specific delivery period and wait to set the futures price at a later
date. Furthermore, due to the more limited supply for organic ingredients, we may commit to purchase organic ingredients in
advance to help ensure supply. Ordinarily, we do not enter into long-term contracts beyond a year to purchase corn and soybean
meal or hedge against increases in the prices of corn and soybean meal. Corn and soybean meal are commodities and are
subject to volatile price changes due to weather, various supply and demand factors, transportation and storage costs,
speculators, agricultural, energy and trade policies in the U.S. and internationally, and global instability that could disrupt the
supply chain.
An important competitive advantage for Cal-Maine Foods is our ability to meet our customers’ evolving needs with a favorable
mix of branded and private-label products of conventional and specialty eggs, including cage-free, organic, brown, free-range,
pasture-raised and nutritionally-enhanced eggs as well as egg products.
HPAI
Outbreaks of HPAI have continued to occur in U.S. poultry flocks. In calendar year 2024, 40.2 million commercial layer hens
and pullets were depopulated due to HPAI, and in calendar year 2025, an additional 32.9 million commercial layer hens and
pullets have been depopulated through March. The United States Depart of Agriculture (the “USDA”) reported that the
estimated table-egg layer flock was approximately 285 million as of March 1, 2025, the lowest level since September 2015.
HPAI is currently widespread in the wild bird population worldwide. We remain dedicated to robust biosecurity programs
across our locations and have invested more than $70 million in biosecurity technology, equipment, procedures, and training
across our locations since the last major HPAI outbreak in 2015. However, no farm is immune from HPAI. For example, during
the third and fourth quarters of fiscal 2024, we experienced HPAI outbreaks within our facilities located in Kansas and Texas,
which are now fully operational. According to the U.S. Centers for Disease Control and Prevention (“CDC”), as of April 1,
2025, there were outbreaks in 996 herds of dairy cows in 17 states, and 70 human cases in the U.S., almost entirely among
poultry and dairy workers. However, in 2024, one of the human cases resulted in severe illness after the patient was exposed to
sick and dead birds in backyard flocks. The patient, who was reported to have underlying health conditions, died in January
2025. There have been no reported cases of person-to-person spread. According to the CDC, the human health risk to the U.S.
public from the HPAI virus is considered to be low. The extent of possible future outbreaks among U.S. commercial egg layer
flocks, with heightened risk during migration seasons, cannot be predicted. According to the USDA, HPAI cannot be
transmitted through safely handled and properly cooked eggs. There is no known risk related to HPAI associated with eggs that
are currently in the market and no eggs have been recalled. For additional information, see the 2024 Annual Report, Part II Item
7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – HPAI.”
We have taken proactive steps to help mitigate the tight egg supply situation across the country. Our efforts resulted in a 14%
increase in the average number of layer hens (reflecting both organic and inorganic expansion) and a 24% increase in total
chicks hatched during the third quarter of fiscal 2025 compared to the prior-year quarter. Our breeder flocks increased 33% as
of the end of the third fiscal quarter of 2025 compared to the end of the prior-year quarter. We also continue to invest in
expansion projects, including expected completion in calendar 2025 of approximately $60 million in ongoing expansion
projects within our current operations that are expected to add approximately 1.1 million cage-free layer hens and 250,000
pullets, and the successful conversion of a new egg processing facility and hatchery in Dexter, Missouri, projected to add
additional capacity of 1.2 million free range hens by calendar year end.
CAGE-FREE EGGS
Ten states have passed legislation or regulations mandating minimum space or cage-free requirements for egg production or
mandated the sale of only cage-free eggs and egg products in their states, with implementation of these laws ranging from
January 2022 to January 2030. These states represent approximately 27% of the U.S. total population according to the 2020
U.S. Census. California, Massachusetts, Colorado, Michigan, Oregon, Washington, and Nevada, which collectively represent
approximately 23% of the total estimated U.S. population, have cage-free legislation currently in effect. Due to the national egg
shortage caused by HPAI, Nevada temporarily suspended the cage-free egg mandate and other states are considering similar
actions.
A significant number of our customers have announced goals to either exclusively offer cage-free eggs or significantly increase
the volume of cage-free egg sales in the future, subject in most cases to availability of supply, affordability and consumer
demand, among other contingencies. Our customers typically do not commit to long-term purchases of specific quantities or
types of eggs with us, and as a result, it is difficult to accurately predict customer requirements for cage-free eggs. We are
focused on adjusting our cage-free production capacity with a goal of meeting the future needs of our customers in light of
changing state requirements and our customers’ goals. As always, we strive to offer a product mix that aligns with current and
anticipated customer purchase decisions. We are engaging with our customers to help them meet their announced goals and
needs. We have invested significant capital in recent years to acquire and construct cage-free facilities, and we expect our focus
for future expansion will continue to include cage-free facilities. Our volume of cage-free egg sales has continued to increase
and account for a larger share of our product mix. Cage-free egg revenue represented approximately 19.2% of our total shell
egg revenue for the third quarter of fiscal year 2025. At the same time, we understand the importance of our continued ability to
provide conventional eggs in order to provide our customers with a variety of egg choices and to address hunger in our
communities.
For additional information, see the 2024 Annual Report, Part I Item 1, “Business – Specialty Eggs,” “Business – Growth
Strategy” and “Business – Government Regulation,” and the first risk factor in Part I Item 1A, “Risk Factors” under the sub-
heading “Legal and Regulatory Risk Factors.”
ACQUISITIONS
Effective February 3, 2025, we acquired certain assets of Deal-Rite Foods, Inc. and certain of its affiliates (“Deal-Rite”). The
assets acquired included two feed mills, storage facilities, usable grain, vehicles, related equipment and a retail feed sales
business located in North Carolina. The acquired assets will produce and deliver feed to our nearby shell egg production
facilities.
During the first quarter of fiscal 2025, we acquired substantially all the commercial shell egg production, processing and egg
products breaking assets of ISE America, Inc. and certain of its affiliates (“ISE”). The assets acquired included commercial
shell egg production and processing facilities with a capacity at the time of acquisition of approximately 4.7 million laying
hens, including 1.0 million cage-free, and 1.2 million pullets, feed mills, approximately 4,000 acres of land, inventories and an
egg products breaking facility. The acquired assets also include an extensive customer distribution network across the Northeast
and Mid-Atlantic states, and production operations in Maryland, New Jersey, Delaware and South Carolina. These production
assets are our first in Maryland, New Jersey and Delaware. We believe this acquisition provides us with an opportunity to
significantly enhance our market reach in the Northeast and Mid-Atlantic states. See further discussion in
Note 2 – Acquisition
of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.
Effective on September 9, 2024, we completed a strategic investment with Crepini LLC, establishing a new egg products and
prepared foods venture. Crepini LLC, founded in 2007, grew its brand throughout the United States and Mexico featuring egg
wraps, protein pancakes, crepes, and wrap-ups, which are sold online and in over 3,500 retail stores. The new entity, located in
Hopewell Junction, New York, operates as Crepini Foods LLC (“Crepini”). We capitalized Crepini with approximately $6.75
million in cash to purchase additional equipment and other assets and fund working capital in exchange for a 51% interest in the
new venture. Crepini LLC contributed its existing assets and business in exchange for a 49% interest in the new venture.
In fiscal 2022, we announced a strategic investment in a new entity, MeadowCreek Food, LLC (“MeadowCreek”), which
became a majority-owned subsidiary. During March 2023, MeadowCreek began operations with a focus on being a leading
provider of hard-cooked eggs. During second quarter 2025, we acquired the remaining ownership interests in MeadowCreek
and it became a wholly-owned subsidiary.
In second quarter 2024, we acquired the assets of Fassio Egg Farms, Inc. (“Fassio”) related to its commercial shell egg
production and processing business. Fassio owned and operated commercial shell egg production and processing facilities with
a capacity at the time of acquisition of approximately 1.2 million laying hens, primarily cage-free, a feed mill, pullets, a
fertilizer production and composting operation and land located in Erda, Utah, outside Salt Lake City. This acquisition provided
us with an opportunity to expand our market presence in Utah and the western U.S., particularly for cage-free eggs. In fourth
quarter 2024, we acquired a broiler processing plant, hatchery and feed mill in Dexter, Missouri, which we repurposed for use
in shell egg production.
EXECUTIVE OVERVIEW
For the third quarter and first three quarters of fiscal 2025, we recorded a gross profit of $716.1 million and $1,319.4 million,
respectively, compared to $218.6 million and $355.1 million, respectively, for the same periods of fiscal 2024, primarily driven
by an increase in the net average selling price of shell eggs, primarily conventional egg prices, as well as an increase in total
dozens sold. Our results were also positively impacted by lower feed costs and our recent acquisitions discussed above,
partially offset by an increase in the volume and price of outside egg purchases.
Our net average selling price per dozen for the third quarter of fiscal 2025 was $4.060 compared to $2.247 in the prior-year
period. Conventional egg prices per dozen were $4.766 compared to $2.152 for the prior-year period, and specialty egg prices
per dozen were $2.784 compared to $2.415 for the prior-year period. Egg prices in the third quarter of fiscal 2025 were elevated
compared to the prior-year period primarily due to the resurgence of HPAI outbreaks, which decreased supply during the higher
seasonal demand cycle. According to the USDA, the monthly average size of the layer hen flock from December 2024 through
February (which most closely aligns with our third fiscal quarter) 2025 was approximately 302.7 million hens, which was a
decrease of 11.0 million layers, or 3.5%, compared to the same period in the prior year. The daily average price for the Urner
Barry southeast large index for the third quarter of fiscal 2025 increased 156% from the comparable period in the prior year.
Subsequent to third quarter fiscal 2025, the Urner Barry southeast large index decreased to $3.99 per dozen as of April 4, 2025
from a high of $8.69 per dozen as of February 28, 2025. For more information about historical shell egg prices, see Part I Item I
of our 2024 Annual Report.
Our dozens sold for the third quarter of fiscal 2025 increased 10.2% compared to the third quarter of fiscal 2025. Demand was
strong during the third fiscal quarter, which is typically a period of higher seasonal demand. We believe that other factors
positively impacting demand included severe weather events during the quarter, including the historic snowstorms in the
southern U.S. in January 2025, which prompted families to stock up on staples including eggs, and reported recommendations
of eggs as a good source of lean protein for individuals taking GLP-1 medications. In addition to strong consumer demand
during the quarter, we had an increase in production capacity with the acquisitions of the commercial shell egg production and
processing business of ISE during the first quarter of fiscal 2025.
Our farm production costs per dozen produced for the third quarter of fiscal 2025 decreased 5.7%, or $0.06 compared to the
prior year period, primarily due to lower feed costs. Feed costs per dozen produced decreased 9.6%, or $0.05, compared to the
third quarter of fiscal 2024, primarily due to lower feed ingredient prices. For information about historical corn and soybean
meal prices, see Part I Item I of our 2024 Annual Report. Our egg purchases and other cost of sales increased $163.8 million
quarter-over-quarter and $397.8 million comparing year-to-date periods, primarily due to higher shell egg prices as well as an
increase in dozens purchased to supply eggs for our customers, including those acquired in our ISE acquisition, during the
higher seasonal demand cycle while the nation experienced lower supply due to HPAI.
RESULTS OF OPERATIONS
The following table sets forth, for the periods indicated, certain items from our Condensed Consolidated Statements of Income
expressed as a percentage of net sales.
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 1, 2025
March 2, 2024
March 1, 2025
March 2, 2024
Net sales
100.0
100.0
100.0
100.0
Cost of sales
49.5
68.9
58.2
78.9
Gross profit
50.5
31.1
41.8
21.1
Selling, general and administrative
5.6
9.3
7.0
11.6
(Gain) loss on involuntary conversions
(1.4)
(0.6)
Operating income
44.9
23.2
34.8
10.1
Total other income, net
1.9
3.2
1.6
2.2
Income before income taxes
46.8
26.4
36.4
12.3
Income tax expense
10.9
5.5
8.7
2.6
Net income
35.9
20.9
27.7
9.7
Less: Loss attributable to noncontrolling
interest
(0.1)
Net income attributable to Cal-Maine
Foods, Inc.
35.9
20.9
27.7
9.8
NET SALES
Total net sales for the third quarter of fiscal 2025 were $1.4 billion compared to $703.1 million for the same period of fiscal
Shell egg sales represented 94.9% and 96.1% of total net sales for the third quarters of fiscal 2025 and 2024, respectively. The
Company’s shell egg offerings, for both branded and private-label products, include specialty and conventional shell eggs.
Specialty shell eggs include cage-free, organic, brown, free-range, pasture-raised and nutritionally enhanced eggs. Conventional
shell eggs sales represent all other shell egg sales not sold as specialty shell eggs. The Company’s egg products offerings
include liquid and frozen egg products and ready-to-eat products such as hard-cooked eggs, egg wraps, protein pancakes, crepes
and wrap-ups. Other sales represent feed sales, miscellaneous byproducts and resale products.
Total net sales for the thirty-nine weeks ended March 1, 2025 were $3.2 billion, compared to $1.7 billion for the comparable
period of fiscal 2024.
Shell egg sales represented 94.7% and 95.4% of total net sales for the thirty-nine weeks ended March 1, 2025 and March 2,
2024, respectively.
The table below presents net sales in key categories (in thousands, except percentage data):
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 1, 2025
March 2, 2024
% Change
March 1, 2025
March 2, 2024
% Change
Shell Eggs
1,345,382
675,912
99.0
2,990,756
1,608,377
85.9
Egg products
61,024
21,759
180.5
136,850
63,994
113.8
Other
11,279
5,405
108.7
30,621
13,283
130.5
Total net sales
1,417,685
703,076
101.6
3,158,227
1,685,654
87.4
The table below presents an analysis of our shell egg sales (in thousands, except percentage data):
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 1, 2025
March 2, 2024
March 1, 2025
March 2, 2024
Shell egg sales
Conventional
1,016,438
75.6
413,619
61.2
2,118,065
70.8
919,498
57.2
Specialty
328,944
24.4
262,293
38.8
872,691
29.2
688,879
42.8
Total shell egg sales
1,345,382
100.0
675,912
100.0
2,990,756
100.0
1,608,377
100.0
Dozens sold
Conventional
213,247
64.3
192,182
63.9
622,833
64.1
566,174
65.7
Specialty
118,148
35.7
108,597
36.1
348,385
35.9
295,904
34.3
Total dozens sold
331,395
100.0
300,779
100.0
971,218
100.0
862,078
100.0
Net average selling price per dozen
Conventional
4.766
2.152
3.401
1.624
Specialty
2.784
2.415
2.505
2.328
All shell eggs
4.060
2.247
3.079
1.866
Shell egg sales
Third Quarter – Fiscal 2025 vs. Fiscal 2024
In the third quarter of fiscal 2025, conventional egg sales increased $602.8 million, or 145.7%, compared to the third
quarter of fiscal 2024, primarily due to a 121.5% increase in the prices for conventional eggs, which resulted in a
$557.4 million increase in net sales, and a 11.0% increase in the volume of conventional eggs sold, which resulted in a
$45.3 million increase in net sales. Results for the third quarter of 2025 were positively impacted by our acquisition of
ISE during the current fiscal year as well as the resumption of full operations at our facility in Chase, KS, which was
shut down in the prior year quarter due to an HPAI outbreak.
Specialty egg sales increased $66.7 million, or 25.4%, in the third quarter of fiscal 2025 compared to the third quarter
of fiscal 2024, primarily due to a 15.3% increase in prices for specialty eggs, which resulted in a $43.6 million
increase in net sales and a 8.8% increase in the volume of specialty eggs sold, which resulted in a $23.1 million
increase in net sales.
See “Executive Overview” above for additional discussion.
Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024
- For the thirty-nine weeks ended March 1, 2025, conventional egg sales increased $1.2 billion, or 130.4%, compared to
the same period of fiscal 2024, primarily due to the increase in the prices for conventional shell eggs. Prices for
conventional eggs increased 109.4%, which resulted in a $1.1 billion increase in net sales. A 10.0% increase in the
volume of conventional eggs sold resulted in a $92.0 million increase in net sales.
Specialty egg sales increased $183.8 million, or 26.7%, for the thirty-nine weeks ended March 1, 2025 compared to
the same period in fiscal 2024, primarily due to a 17.7% increase in the volume of specialty eggs sold, which resulted
in a $122.2 million increase in net sales and a 7.6% increase in prices for specialty eggs, which resulted in a $61.7
million increase in net sales.
Egg products sales
Third Quarter – Fiscal 2025 vs. Fiscal 2024
Egg products sales increased $39.3 million, or 180.5%, for the third quarter of fiscal 2025 compared to the same
period of fiscal 2024, primarily due to a 200.5% increase in sales of liquid eggs, which had a $22.0 million positive
impact on net sales, and a 46.1% increase in liquid eggs pounds sold, which resulted in a $6.6 million increase in net
sales. Results for the third quarter of 2025 were positively impacted by our recent acquisition of ISE, which included a
breaking facility.
Sales from hard-cooked eggs increased $6.6 million or 181.5% in the third quarter of fiscal 2025 compared to fiscal
2024 as more processing capabilities are coming online from our investments in MeadowCreek.
Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024
- Egg products sales increased $72.9 million, or 113.8%, primarily due to a 118.0% increase in sales of liquid eggs,
which had a $31.6 million positive impact on net sales, and a 42.0% increase in liquid eggs pounds sold, which
resulted in a $17.4 million increase in net sales.
Sales from hard-cooked eggs increased $18.7 million, or 188.6%, in the first three quarters of fiscal 2025 compared to
the same period in fiscal 2024, primarily for the reasons described above.
Other
Other sales increased compared to the prior year periods primarily due to higher feed sales related to our ISE
acquisition.
COST OF SALES
Cost of sales consists of costs directly related to producing, processing and packing shell eggs, purchases of shell eggs from
outside sources, processing and packing of egg products and other non-egg costs. Farm production costs are those costs
incurred at the egg production facility, including feed, facility (including labor), hen amortization and other related farm
production costs.
The following table presents the key variables affecting our cost of sales (in thousands, except cost per dozen data):
Thirteen Weeks Ended
Thirty-nine Weeks Ended
March 1, 2025
March 2, 2024
Change
March 1, 2025
March 2, 2024
Change
Cost of sales
Farm production
266,056
248,650
7.0
766,003
760,525
0.7
Processing, packaging,
and warehouse
101,631
86,423
17.6
292,165
253,096
15.4
Egg purchases and other
cost of sales
291,703
127,925
128.0
658,182
260,375
152.8
Egg products
42,180
21,506
96.1
122,502
56,523
116.7
Total cost of sales
701,570
484,504
44.8
1,838,852
1,330,519
38.2
Farm production costs (per
dozen produced)
Feed
0.492
0.544
(9.6)
0.489
0.564
(13.3)
Other
0.418
0.421
(0.7)
0.420
0.431
(2.6)
Total farm production cost
0.910
0.965
(5.7)
0.909
0.995
(8.6)
Outside egg purchases
(average cost per dozen)
5.10
2.44
109.0
3.69
2.09
76.6
Dozens produced
293,087
259,527
12.9
847,962
774,984
9.4
Percent produced to sold
88.4%
86.3%
2.4
87.3%
89.9%
(2.9)
Farm Production
Third Quarter – Fiscal 2025 vs. Fiscal 2024
Feed costs per dozen produced decreased 9.6% in the third quarter of fiscal 2025 compared to the third quarter of
fiscal 2024. This decrease was primarily due to lower prices for soybean meal, one of our primary feed ingredients.
The decrease in feed cost per dozen resulted in a decrease in cost of sales of $15.2 million for the third quarter of fiscal
2025 compared to the prior period quarter.
For the third quarter of fiscal 2025, the average Chicago Board of Trade (“CBOT”) daily market price was $4.68 per
bushel of corn and $298 per ton of soybean meal, representing an increase of 3.8% and a decrease of 19.3%,
respectively, as compared to the average CBOT daily market prices for the third quarter of fiscal 2024.
Other farm production costs decreased primarily due to lower flock amortization. Feed costs reached their peak in the
second quarter of fiscal 2023 and have since trended downward. Lower costs result in lower capitalized values of the
flocks during the grow out phase, which reduced amortization cost over time.
Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024
Feed costs per dozen produced decreased 13.3% in the thirty-nine weeks ended March 1, 2025 compared to the same
period of fiscal 2024, primarily due to lower feed ingredient prices. The decrease in feed cost per dozen resulted in a
decrease in cost of sales of $63.6 million compared to the prior year period.
For the year-to-date period, the average CBOT daily market price was $4.29 per bushel of corn and $316 per ton of
soybean meal, representing decreases of 11.8% and 21.5%, respectively, compared to the average CBOT daily market
prices for the comparable period in the prior year.
Other farm production costs decreased due to lower flock amortization, for the reasons described above.
Current indications for corn and soybean project a favorable stocks-to-use ratio near the levels prevailing today for the
remainder of fiscal 2025; however, as long as outside factors remain uncertain (including weather patterns and global supply
chain disruptions), volatility could remain.
Processing, packaging, and warehouse
Third Quarter – Fiscal 2025 vs. Fiscal 2024
Processing, packaging, and warehouse costs increased 17.6% compared to the third quarter of fiscal 2024 due to a
13.5% increase in the volume of processed dozens as well as an increase in costs of packaging materials.
Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024
Processing, packaging, and warehouse costs increased 15.4% compared to the first three quarters of fiscal 2025,
primarily due a 10.3% increase in the volume of processed dozens as well as an increase in costs of packaging
materials.
Egg purchases and other cost of sales
Third Quarter – Fiscal 2025 vs. Fiscal 2024
Costs in this category increased primarily due to higher shell egg prices as the average cost per dozen of outside egg
purchases increased 109.0% compared to third quarter of fiscal 2024, as well as due to an increase of 8.8% in dozens
purchased. Dozens purchased increased due to purchasing more eggs to supply our customers during the higher
seasonal demand cycle while the nation experienced lower supply due to HPAI.
Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024
Costs in this category increased primarily due to higher shell egg prices as the average cost per dozen of outside egg
purchases increased 76.6% compared to fiscal 2024, as well as an increase of 46.2% in dozens purchased, primarily
for the reasons described above.
GROSS PROFIT
Gross profit for the thirteen weeks ended March 1, 2025 was $716.1 million compared to $218.6 million for the same period of
2024. Gross profit for the thirty-nine weeks ended March 1, 2025 was $1.3 billion compared to $355.1 million for the same
period of 2024. The increases were primarily due to higher net average selling prices, particularly for conventional eggs, and higher volumes, as well as lower feed ingredient prices, partially offset by the increase in volume and price of outside egg purchases.
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES
Selling, general, and administrative (“SGA”) expenses include costs of delivery, marketing, and other general and
administrative expenses. Delivery expense includes contract trucking expense and all costs to maintain and operate our fleet of
trucks to deliver products to customers including the related payroll expenses. Marketing expense includes franchise fees that
are submitted to Eggland’s Best, Inc. (“EB”) to support the EB brand, brokerage and commission fees, and other general
marketing expenses such as payroll expenses for our in-house sales team. Other general and administrative expenses include
corporate payroll related expenses and other general corporate overhead costs. The following table presents an analysis of our
SGA expenses (in thousands):
Thirteen Weeks Ended
March 1, 2025
March 2, 2024
$ Change
% Change
Delivery expense
23,476
18,832
4,644
24.7
Marketing expense
11,240
14,149
(2,909)
(20.6)
Other general and administrative
expenses
45,251
33,039
12,212
37.0
Total
79,967
66,020
13,947
21.1
Third Quarter – Fiscal 2025 vs. Fiscal 2024
Delivery expense
The increased delivery expense is primarily due to an increase in our sales volumes of egg and egg products compared
to the prior year period. Contract trucking expenses increased in connection with our acquisition of ISE and our
facility in Chase, KS being fully operational in the current fiscal quarter. We also obtained some new business and
additional shipping routes in order to meet our customers’ needs at their locations.
Marketing expense
The decrease in marketing expense is primarily due to a decrease in franchise fees. The higher prices for conventional
eggs compared to specialty eggs diminished the need to promote specialty eggs; as a result EB temporarily reduced the
related franchise fees for certain specialty egg brands to encourage continued production of these branded eggs.
Other general and administrative expense
The increase in other general and administrative expense is primarily due both to an increase in the accrual for
anticipated employee bonuses and to the increased adjustment to the fair value of contingent consideration associated
with the Fassio acquisition. See further discussion in
Note 4 – Fair Value Measurements
of the Notes to Condensed
Consolidated Financial Statements included in this Quarterly Report.
Thirty-nine Weeks Ended
March 1, 2025
March 2, 2024
$ Change
% Change
Delivery expense
68,206
54,229
13,977
25.8
Marketing expense
40,666
38,809
1,857
4.8
Litigation loss contingency accrual
19,648
(19,648)
(100.0)
Other general and administrative
expenses
110,660
82,158
28,502
34.7
Total
219,532
194,844
24,688
12.7
Thirty-six weeks – Fiscal 2025 vs. Fiscal 2024
Delivery expense
The increased delivery expense is primarily due to the reasons described above
Marketing expense
The increase in marketing expense is primarily due to an increase in franchise fees in the first half of fiscal 2025 as
specialty egg sales increased, partially offset by the reduction in fees in the third quarter of fiscal 2025 described
above.
Litigation loss contingency accrual
In the second quarter of fiscal 2024, we accrued a $19.6 million loss contingency relating to a jury decision returned in
pending anti-trust litigation. See further discussion in
Note 10 - Commitments and Contingencies
of the Notes to
Condensed Consolidated Financial Statements included in this Quarterly Report.
Other general and administrative expense
The increase in other general and administrative expense is primarily for the reasons described above, as well as costs
associated with the acquisition of ISE assets that occurred during the first quarter of fiscal 2025.
GAIN ON INVOLUNTARY CONVERSION
In the third quarter of fiscal 2024, we recorded a gain of $9.9 million due to recoveries under indemnity and insurance programs
that exceeded the amortized book value of the covered assets and our direct costs, primarily related to the HPAI outbreak at our
Kansas facility.
OPERATING INCOME
For the third quarter of fiscal 2025, we recorded operating income of $635.7 million compared to operating income of $162.8
million for the same period of fiscal 2024.
For the thirty-nine weeks ended March 1, 2025, we recorded operating income of $1.1 billion compared to operating income of
$170.3 million for the same period of fiscal 2024.
OTHER INCOME (EXPENSE)
Total other income (expense) consists of items not directly charged or related to operations, such as interest income and
expense, equity in income or loss of unconsolidated entities, and patronage dividends, among other items. Patronage dividends
are paid to us from our membership in the EB cooperative.
For the third quarter of fiscal 2025, we earned $12.8 million of interest income compared to $7.8 million for the same period of
fiscal 2024, primarily due to higher average cash and cash equivalents and investment securities available-for-sale balances and
yields. The Company recorded interest expense of $146 thousand and $247 thousand for the third quarters ended March 1, 2025
and March 2, 2024, respectively.
For the thirty-nine weeks ended March 1, 2025, we earned $32.6 million of interest income compared to $22.4 million for the
same period of fiscal 2024, primarily due to higher average cash and cash equivalents and investment securities available-for-
sale balances and yields. The Company recorded interest expense of $457 thousand and $523 thousand for the thirty-nine weeks
ended March 1, 2025 and March 2, 2024, respectively.
INCOME TAXES
For the third quarter of fiscal 2025, our pre-tax income was $663.0 million, compared to $185.2 million for the third quarter of
fiscal 2024. Income tax expense of $154.9 million was recorded for third quarter 2025 with an effective tax rate of 23.4%. This
includes the discrete tax benefit of $5.7 million associated with the fiscal 2024 provision-to-return adjustments. Excluding the
discrete tax benefit, income tax expense was $160.8 million for the third quarter of fiscal 2025 with an adjusted effective tax
rate of 24.2%. For the third quarter 2024, income tax expense was $38.8 million with an effective tax rate of 21.0%. This
includes the discrete tax benefit of $6.4 million associated with the fiscal 2023 provision-to-return adjustments. Excluding the
discrete tax benefit, income tax expense was $45.2 million with an adjusted effective tax rate of 24.4%.
For the thirty-nine weeks ended March 1, 2025, pre-tax income was $1.1 billion, compared to $208.0 million for the same
period of fiscal 2024. Income tax expense of $273.8 million was recorded for the thirty-nine weeks ended March 1, 2025 with
an effective tax rate of 23.8%. This includes the discrete tax benefit of $5.7 million associated with the fiscal 2024 provision-to-
return adjustments. Excluding the discrete tax benefit, income tax expense was $279.5 million with an adjusted effective tax
rate of 24.3%. For the same period of fiscal 2024, income tax expense was $44.7 million with an effective tax rate of 21.5%.
This includes the discrete tax benefit of $6.4 million associated with the fiscal 2023 provision-to-return adjustments. Excluding
the discrete tax benefit, income tax expense was $51.0 million with an adjusted effective tax rate of 24.5%.
Items causing our effective tax rate to differ from the federal statutory income tax rate of 21% are state income taxes, certain
federal tax credits and certain items included in income or loss for financial reporting purposes that are not included in taxable
income or loss for income tax purposes, including tax exempt interest income, certain nondeductible expenses, and net income
or loss attributable to noncontrolling interest.
NET INCOME ATTRIBUTABLE TO CAL-MAINE FOODS, INC.
Net income attributable to Cal-Maine Foods, Inc. for the third quarter ended March 1, 2025 was $508.5 million, or $10.42 per
basic and $10.38 per diluted common share, compared to net income attributable to Cal-Maine Foods, Inc. of $146.7 million, or
$3.01 per basic and $3.00 per diluted common share, for the same period of fiscal 2024.
Net income attributable to Cal-Maine Foods, Inc. for the thirty-nine weeks ended March 1, 2025, was $877.6 million, or $17.99
per basic and $17.92 per diluted common share, compared to net income attributable to Cal-Maine Foods, Inc. of $164.6
million or $3.38 per basic and $3.37 per diluted common share, for the same period of fiscal 2024.
LIQUIDITY AND CAPITAL RESOURCES
Working Capital and Current Ratio
Our working capital was $1.5 billion at March 1, 2025 compared to $1.0 billion at June 1, 2024. The calculation of working
capital is defined as current assets less current liabilities. Our current ratio was 3.9 at March 1, 2025 compared to 5.5 at June 1,
2024. The decrease in our current ratio is primarily due to the increase in both income taxes and trade payables. The current
ratio is calculated by dividing current assets by current liabilities.
Cash Flows from Operating Activities
For the thirty-nine weeks ended March 1, 2025, $811.7 million in net cash was provided by operating activities, compared to
$237.6 million provided by operating activities for the comparable period in fiscal 2024. The increase in cash flow from
operating activities resulted primarily from higher net average selling prices per dozen, particularly for conventional eggs,
increased volume of sales and a decrease in feed ingredient costs compared to the prior-year period, partially offset by the
increase in volume and price of outside egg purchases.
Cash Flows from Investing Activities
For the thirty-nine weeks ended March 1, 2025, $385.1 million was used in investing activities, primarily due to the acquisition
of assets of ISE, and purchases of property, plant and equipment compared to $118.4 million used in investing activities in the
same period of fiscal 2024, primarily due to purchases of investment securities. Purchases of investment securities were $813.1
million during the thirty-nine weeks ended March 1, 2025 and sales and maturities of investment securities were $654.4 million
during the period. Sales and maturities of investment securities were $273.9 million in the prior year period while purchases of
investment securities were $243.5 million during the period. The increase in sales and maturities of investment securities is
primarily due to the maturities of short-term investments during the first three quarters of fiscal 2025. Cash paid for business
acquisitions was $116.2 million in the thirty-nine weeks ended March 1, 2025, primarily related to the ISE acquisition, and
$53.7 million in the prior year period, related to the Fassio acquisition. Purchases of property, plant and equipment were $115.4
million and $96.0 million in the first three quarters of fiscal 2025 and 2024, respectively, primarily reflecting progress on our
construction projects.
Cash Flows from Financing Activities
We paid dividends of $160.8 million for the thirty-nine weeks ended March 1, 2025 compared to $43.0 million in the same
prior-year period.
As of March 1, 2025, cash increased $259.4 million since June 1, 2024, compared to $74.3 million during the same period of
fiscal 2024. The increase is primarily due to the increase in net sales during fiscal 2025.
Credit Facility
On November 15, 2021, we entered into a credit agreement that provides for a senior secured revolving credit facility (the
“Credit Facility”), in an initial aggregate principal amount of up to $250 million with a five-year term. As of March 1, 2025, no
amounts were borrowed under the Credit Facility and we had $4.7 million in outstanding standby letters of credit issued under
our Credit Facility for the benefit of certain insurance companies. On March 25, 2025, we entered into the Second Amendment
to the Credit Facility. Refer to Part I. Item I, Notes to Consolidated Financial Statements,
Note 11 – Subsequent Events
included in this report, Exhibit 10.2 to this report and Part II Item 8, Notes to Consolidated Financial Statements and
Supplementary Data, Note 10 - Credit Facility included in our 2024 Annual Report for further information regarding our long-
term debt.
Share Repurchase Program
On February 25, 2025, the Board of Directors approved a new $500 million share repurchase program. The share repurchase
program authorizes the Company, in management’s discretion, to repurchase Common Stock from time to time for an aggregate
purchase price up to $500 million (exclusive of any fees, taxes, commissions or other expenses related to such repurchases),
subject to market conditions and other factors. The actual timing, number and value of shares repurchased under the program
will be determined by management in its discretion and will depend on a number of factors, including, but not limited to, the
market price of the Common Stock and general market and economic conditions.
The Company expects to strategically and opportunistically repurchase shares from time to time through solicited or unsolicited
transactions in the open market, in privately negotiated transactions or by other means in accordance with securities laws. It is
also possible that the Company could use a portion of its share repurchase program to repurchase some of the shares of the
Company’s Common Stock held by the family of our late founder, Fred R. Adams Jr., as part of their potential portfolio
diversification. Any repurchases from the family would require special approval from a Special Committee of the Board of
Directors. The Company expects that share repurchases under the program will be funded from one or a combination of
existing cash balances and future free cash flow. The share repurchase program does not obligate the Company to repurchase
any specific amount of shares, does not have an expiration date, and may be suspended, modified or discontinued at any time
without prior notice.
Dividends
In accordance with our variable dividend policy, we will pay a cash dividend totaling approximately $169.5 million, or
approximately $3.456 per share, to holders of our Common Stock and Class A Common Stock with respect to our third quarter
of fiscal 2025. The amount paid per share will vary based on the number of outstanding shares on the record date. The dividend
is payable on May 15, 2025 to holders of record on April 30, 2025.
Material Cash Requirements
Material cash requirements for operating activities primarily consist of feed ingredients, processing, packaging and warehouse
costs, employee related costs, and other general operating expenses, which we expect to be paid from our cash from operations
and cash and investment securities on hand for at least the next 12 months. While volatile egg prices and feed ingredient costs,
among other things, make long-term predictions difficult, we have substantial liquid assets and availability under our Credit
Facility to fund future operating requirements.
Our material cash requirements for capital expenditures consist primarily of our construction projects to increase our cage-free
production capacity. We continue to monitor the increasing demand for cage-free eggs and to engage with our customers in
efforts to achieve a smooth transition toward their announced timelines for cage-free egg sales. The following table presents
material construction projects approved as of March 1, 2025 (in thousands):
Project(s) Type
Projected
Completion
Projected Cost
Spent as of March 1,
2025
Remaining
Projected Cost
Cage-Free Layer & Pullet Houses
Fiscal 2025
4,396
3,796
600
Feed Mills
Fiscal 2026
16,593
8,055
8,538
Egg Products Expansion
Fiscal 2026
20,213
7,093
13,120
Cage-Free Layer & Pullet Houses
Fiscal 2026
199,667
155,444
44,223
240,869
174,388
66,481
These projects include the addition of five new cage-free layer houses and two pullet houses across our locations in Florida,
Georgia, Utah and Texas. We expect the projects to be completed in calendar 2025 with expected additional production
capacity for approximately 1.1 million cage-free layer hens and 250 thousand pullets. We are also investing $15 million to
expand our egg products processing facility in Blackshear, Georgia to add extended shelf-life liquid eggs products.
We believe our current cash balances, investments, projected cash flows from operations, and available borrowings under our
Credit Facility will be sufficient to fund our capital expenditure cash needs for at least the next 12 months and to fund our
capital commitments currently in place thereafter.
IMPACT OF RECENTLY ISSUED/ADOPTED ACCOUNTING STANDARDS
For information on changes in accounting principles and new accounting policies, see
Note 1 - Summary of Significant
Accounting Policies
of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.
CRITICAL ACCOUNTING ESTIMATES
Critical accounting estimates are those estimates made in accordance with U.S. generally accepted accounting principles that
involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our
financial condition or results of operations. There have been no changes to our critical accounting estimates identified in our
2024 Annual Report.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-12-01 to 2025-03-01 | $1.42bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-06-02 to 2025-03-01 | $3.16bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-12-01 to 2025-03-01 | $701.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-06-02 to 2025-03-01 | $1.84bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-12-01 to 2025-03-01 | $716.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-06-02 to 2025-03-01 | $1.32bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-12-01 to 2025-03-01 | $80.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-06-02 to 2025-03-01 | $219.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-12-01 to 2025-03-01 | $635.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-06-02 to 2025-03-01 | $1.10bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-12-01 to 2025-03-01 | $154.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-06-02 to 2025-03-01 | $273.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-12-01 to 2025-03-01 | $508.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-06-02 to 2025-03-01 | $877.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-12-01 to 2025-03-01 | $10.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-06-02 to 2025-03-01 | $17.92 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-12-01 to 2025-03-01 | $10.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-06-02 to 2025-03-01 | $17.99 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-12-01 to 2025-03-01 | 48,971,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-06-02 to 2025-03-01 | 48,962,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-06-02 to 2025-03-01 | $811.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-06-02 to 2025-03-01 | $115.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2024-06-02 to 2025-03-01 | $160.8m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2025-03-01 | $497.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-01 | $1.98bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-01 | $3.08bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-01 | $513.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-01 | $694.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-01 | $2.38bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001562762-25-000084. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.